Visually Significant Cystoid Macula Edema After Glaucoma Drainage Implant Surgery.

Area of Science:

• Ophthalmology
• Glaucoma Surgery
• Macular Edema

Background:

• Glaucoma drainage implants (GDIs) are used to manage intraocular pressure (IOP) in glaucoma patients.
• Postoperative complications, including cystoid macular edema (CME), can impact visual outcomes.
• Understanding the incidence and risk factors for CME after GDI surgery is crucial for patient management.

Purpose of the Study:

• To determine the incidence of visually significant CME following GDI surgery.
• To identify risk factors associated with the development of CME post-GDI.
• To analyze the prognosis and treatment outcomes for CME after GDI surgery.

Main Methods:

• A cohort of 185 eyes from glaucoma patients undergoing GDI surgery was analyzed.
• Patients were categorized into groups with and without visually significant CME.
• Data collected included pre- and post-operative visual acuity, IOP, medication use, and complications, with Optical Coherence Tomography (OCT) used for macular assessment.

Main Results:

• A 22.2% incidence of visually significant CME was observed post-GDI surgery.
• Higher rates of CME were associated with pre-operative NSAID use and prior glaucoma surgeries.
• CME cases showed a higher incidence of iritis, epiretinal membrane, and hypotony.
• Steroid treatment led to resolution of macular edema and improved visual acuity in CME eyes without compromising IOP control.

Conclusions:

• The incidence of CME after GDI surgery may be higher in real-world clinical settings than in trials.
• Effective management with steroids can restore visual acuity and macular thickness.
• Diligent monitoring and treatment are essential for managing CME post-GDI surgery.